The Globalization of Clinical Trials - Challenges, Opportunities and a Path Forward

June 2010Regulation Pharmaceutical

Abstract

In recent years, pharmaceutical companies have expanded clinical research in emerging markets around the world and increasingly involving populations that traditionally have had limited or no access to clinical trials (other than experimental treatments for communicable diseases). Trial sponsors can increasingly find well qualified investigators from Latin America, Eastern Europe, Asia and other non-European and non-North American regions. By identifying and including them in their trials, industry can build a strong presence in formerly under-served areas, accelerate trial enrollment, and maintain or improve data quality and scientific standards.

Subscribe to reador

Self-regulation is an honourable concept. Proponents of the system emphasise the relative amiability and expediency of dispute resolution mechanisms, and remind industry that to the extent that it is not...Read more

Howard Snoyman

Head: Legal and Ethics, Discovery Health Medical Scheme, South Africa

Increased Evolution of Regulations Affecting the Pharmaceutical Law Practice

The increase of regulations over the last two to five years for pharmaceutical companies has become a nightmare for sales representatives working for those companies and for internal staff charged...Read more

Jean Frydman

Partner, Fox Rothschild, USA

Left to Their Own Devices

The European Union (“EU”) has among its most fundamental goals and principles a convergence of the economies of, and a weakening of internal frontiers between, its member states. Economic...Read more

The Globalization of Clinical Trials - Challenges, Opportunities and a Path Forward

Abstract

Related Papers